Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
12/2006
12/13/2006CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006CN1878466A Biphenyl derivative or salt thereof, pest control agent containing the same as active ingredient
12/13/2006CN1876664A Organometallic complex and organic electroluminescent device using the same
12/13/2006CN1289507C Novel insecticidal pyrrole compounds
12/13/2006CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006CN1289477C N-substituted phenyl carbamate compound with sterilization activity and method for preparing the same
12/13/2006CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006CN1289083C 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
12/13/2006CN1289082C Medicine composition for treating diabetes
12/13/2006CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/12/2006US7148359 Protease inhibitors; viricides; purity, crystal structure
12/12/2006US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006US7148246 Therapy, prevention diseases of fatty acid metabolism, glucose utilization; insulin resistance; antidiabetic agents; antilipemic agents
12/12/2006US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/12/2006US7148224 Pyrazinone derivatives
12/12/2006US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006US7148030 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis
12/12/2006US7148029 Generating antibodies; quantitative analysis
12/12/2006CA2347741C Thiazole-derivatives
12/12/2006CA2281695C Process for the preparation of substituted thiazolidinedione
12/07/2006WO2006130551A2 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
12/07/2006WO2006130469A1 Stimulation of neurite outgrowth by small molecules
12/07/2006WO2006129788A1 Agent for regeneration and/or protection of nerves
12/07/2006WO2006129276A1 Processes for the preparation of stable polymorphic form i of ritonavir
12/07/2006WO2006129164A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
12/07/2006WO2006128688A1 Process for the preparation of pramipexole
12/07/2006US20060276656 Method for the production of fluoromethyl-substituted heterocycles
12/07/2006US20060276521 e.g. N-{4-[2-(4-{[amino(imino)methyl]amino}phenyl)ethyl]-1,3-thiazol-2-yl}acet-amide; vascular adhesion protein (semicarbazide sensitive amine oxidase) inhibitor; antidiabetic, hypotensive agent; non-insulin dependent diabetis obesity, retinopathy complications, atherosclerosis, macular edema
12/07/2006US20060276519 Thiazole derivatives for treating ppar related disorders
12/07/2006US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006US20060276517 Non-systemic control of parasites
12/07/2006US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006US20060275250 Reactive polymers and copolymers, method of their preparation and their use
12/07/2006CA2610692A1 Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves
12/06/2006EP1728787A1 Process for purification of 2-chloro-5-chloromethyl -1,3-thiazole
12/06/2006EP1728784A1 Fluorene derivative
12/06/2006EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006EP1079819B1 Hydroxamic acid derivatives as antibacterials
12/06/2006CN1875026A Platinum complex and luminescent element
12/06/2006CN1875006A Method for the production of fluoromethyl-substituted heterocycles
12/06/2006CN1872845A Method and equipment for preparing 2 ¿C benzothiazole sulphenamide
12/06/2006CN1872844A Method for synthesizing 2 (alpha - phenyl ¿C alpha ¿C methoxycarbonyl - methyl) thiazolidine ¿C 4 - carboxylic acid and mensurating limitation
12/05/2006US7145018 Novel desepoxydidehydroepothilone, useful for treating taxol-resistant cancer
12/05/2006US7145017 Preparation of Aztreonam
12/05/2006US7145006 PNA monomer and precursor
12/05/2006US7144920 asymmetrically-substituted xylylenediamines, e.g., N-(3-aminopropyl)-xylylenediamine; cancer, mucositis, asthma, inflammation, autoimmune disease, psoriasis, restentosis, rheumatoid arthritis, scleroderma, lupus, diabetes, tissue transplantation, osteoporosis, hyperparathyroidism, peptic ulcers, glaucoma
12/05/2006US7144906 Heterocyclic compounds
12/05/2006US7144905 Small molecules used to increase cell death
12/05/2006US7144904 desferrithiocin analogs used as siderophores, for treatment of malaria in humans
12/05/2006US7144903 CCR4 antagonists
12/05/2006US7144902 Prodrugs of thrombin inhibitors
12/05/2006US7144900 Pharmaceutical composition
12/05/2006US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
12/05/2006US7144743 Anionic polymers; ligand joining solid supports; separation of molecules
12/05/2006CA2531834C Pharmaceutical compositions comprising pioglitazone and an insulin secretion enhancer
11/2006
11/30/2006WO2006127945A1 Compositions and methods of treating retinal disease
11/30/2006WO2006126714A1 Activator for peroxisome proliferator-activated receptor
11/30/2006WO2006126581A1 Combination drug
11/30/2006WO2006125805A1 Thiazole derivatives and use thereof
11/30/2006WO2006125687A1 Heteroaroyl-substituted serine amides
11/30/2006WO2006103045B1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
11/30/2006WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/30/2006US20060270857 Production methods of thiazoline compounds and optically active alpha-alkylcysteine
11/30/2006US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
11/30/2006US20060270721 EP4 receptor agonist, compositions and methods thereof
11/30/2006US20060270720 Iminothiazolidinone derivatives as SFRP-1 antagonists
11/30/2006CA2609659A1 Azanaphthalenes, compositions and methods for treating retinal disease
11/30/2006CA2609446A1 Activator for peroxisome proliferator-activated receptor
11/30/2006CA2609243A1 Heteroaroyl-substituted serine amides
11/30/2006CA2607385A1 Thiazole derivatives and their use for the treatment and/or prophylaxis of disorders and diseases
11/29/2006EP1726586A1 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
11/29/2006EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006EP1188752B1 Process for producing substituted alkylamine derivative
11/29/2006EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006CN1871225A Preferentially substituted calcium channel blockers
11/29/2006CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006CN1871220A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
11/29/2006CN1871219A Hexylcarboxanilide
11/29/2006CN1871218A Isopentyl carboxanilides for combating undesired micro-organisms
11/29/2006CN1870996A N-thiazol-2-yl-benzamide derivatives
11/29/2006CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006CN1286834C Benzothiazoles compound
11/29/2006CN1286824C Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action
11/28/2006US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006US7141655 Reagents and procedures for high-specificity labeling
11/28/2006US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006US7141595 Amino benzothiazole compounds with NOS inhibitory activity
11/28/2006US7141533 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides